Navigation Links
C-Reactive Protein, High Sensitivity

ProductsC-Reactive Protein, High Sensitivity
Company ARUP Laboratories
Item C-Reactive Protein, High Sensitivity
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. RCRP high sensitivity C-Reactive Protein (hsCRP)
2. C-Reactive Protein (CRP) Assay
3. C-Reactive Protein Assay
4. C-Reactive Protein - Rapid Test
5. Immunex CRP® C-Reactive Protein
6. C-Reactive Protein
7. C-Reactive Protein, Neonatal
8. Array® 360 Protein, Serology and Drug System
9. Array® 360 CEAL Protein, Serology and Drug System
10. Bence Jones Protein, Qualitative Free Kappa & Lambda Light Chains, Urine
11. Bence Jones Protein, Quantitative Free Kappa Light Chains, Urine
Rapid latex slide agglutination assay for the qualitative and semi-quantitative determination of Rheumatoid Factors in human serum.
The Diamedix immunosimplicity® Is- Rheumatoid Factor Test Kit is an EIA procedure intended for the quantitation of IgM antibodies to IgG antigen. The results are reported in IU/mL, traceable to t
RFScan Latex Test Kit-100
The SYNCHRON CX3 Delta is a critical care clinical system, providing unparalleled testing speed for the most frequently ordered chemistries-Glucose, BUN, Creatinine, Sodium, Potassium Chloride, CO2 C
Medicine Products:
(Date:7/18/2008)...orarily, Canadian researchers report , ,...zy eye in adults is supposed to be impossible, but... -- at least partially and temporarily -- by beami...th lazy eye -- ophthalmologists call it amblyopia ...the other. Early treatment often has a child weari...
(Date:7/18/2008)...vailable in French . , Winnipeg (July 18, 20...titutes of Health Research (CIHR) was announced to...es-Assiniboia and Parliamentary Secretary for Heal... This funding will support three research teams in...al health research. The Mental Health Commission o...
(Date:7/18/2008)...nal immunization awareness campaign to raise aware...ination and increase vaccine complia...Md., July 18 /PRNewswire/ -- The COSHAR Foundation...cation, improvement and,empowerment with a focus o...tional Women,s Health Awareness Day on Saturday, J...
(Date:7/18/2008)...ne fails to ease symptoms, but old drug offers new...s) -- It,s one step forward, one step back in the.... , In one of two studies in the July 19 issue ...ificantly improved Alzheimer,s symptoms. But in a ...prevent the progression of Alzheimer,s -- even tho...
Breaking Medicine News(10 mins):Health News:Magnetic Pulses to Brain Improve Lazy Eye in Adults 2Health News:Magnetic Pulses to Brain Improve Lazy Eye in Adults 3Health News:CIHR announces $4.4 million to improve mental health of Canadians 2Health News:The COSHAR Foundation Participates in Annual Women's Health Awareness Day 2Health News:The COSHAR Foundation Participates in Annual Women's Health Awareness Day 3Health News:Alzheimer's Research Brings Progress, Setbacks 2Health News:Alzheimer's Research Brings Progress, Setbacks 3Health News:Alzheimer's Research Brings Progress, Setbacks 4
...ry licensing (CL) provision in the Patents Act tha...d stockpile Swiss drug maker Roche’s patented drug...ainst the most dreaded avian flu virus. Section 9... without receipt of an application from the indust...
...oxygen consumption, and myocardial activity has be...f heart rate on myocardial oxygen tension (pO2) re...pO2 micro catheters to measure partial oxygen tens...igate the influence of heart rate on myocardial ox...
...as revealed for the first time the AID statistics ...patients and 343 HIV positive cases in the state. ...ourism as it is in the lower Himalayan area with f...edarnath and Rishikesh. The health Minister said:'...
...ydrate metabolism, and is known to increase the se...ucose by the peripheral tissues and proper metabol... on long-term complications. In diabetes, the met...mal and an association between the proper metaboli...
Other Medicine News:Health News:Influence Of Heart Rate On Myocardial Oxygen Tension 2Health News:Carnitine deficiency in children and adolescents with type 1 diabetes 2
(Date:7/15/2008)...to Safety, Escitalopram Will Remain as the Clinica... Report from Decision Resources, WALTHAM, Mass., ... the,world,s leading research and advisory firms f...inds that a drug,s long-term efficacy in preventin...ts who suffer from major,depressive disorder, is t...
(Date:7/15/2008)...ON, July 15 /-Scimitar Equity, LLC is... ADXS), entitled, "The New Generation of,Cancer Im...ebsite: http://www.scimitarequity.com ., Based i...eloping,proprietary Listeria monocytogenes ("Lm") ...r. Yvonne Paterson, Professor of Microbiology at,t...
(Date:7/14/2008)...ng inherited mitochondrial diseases as an archetyp...aging, SAN JOSE, Calif., July 15 /- ...technology company located in San Jose, CA, announ...cal development, triggering a,milestone payment fr...artner. Penwest has begun dosing in a Phase 1a cli...
(Date:7/14/2008)...TAIN VIEW, Calif., July 14 /PRNewswire-FirstCall/ ...y announced it has initiated its,Phase 3 clinical ...nt for,migraine., MAP0004 is orally inhaled and s..., proprietary Tempo(R) inhaler. In the company,s p... relief in as fast as 10 minutes,with relief sust...
Breaking Medicine Technology:Current and Emerging Drugs Continue to Struggle for Patient Share in the Treatment of Major Depressive Disorder 2Advaxis, Inc Initiation Coverage Review Issued By Scimitar Equity, LLC 2Edison Pharma Hits Milestone as A0001 Enters Phase 1 Clinical Development 2MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine 2MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine 3MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine 4Study Points to New Treatments for Polycystic Kidney Disease 16632 1Study Points to New Treatments for Polycystic Kidney Disease 16632 2Joint Center to Focus on Issues of Health Equity During Congressional Black Caucus Spring Health Braintrust 16627 1Joint Center to Focus on Issues of Health Equity During Congressional Black Caucus Spring Health Braintrust 16627 2Pennsylvania Contractor Pleads Guilty to Participating in Fraud Conspiracy at New York Presbyterian Hospital 16625 1Pennsylvania Contractor Pleads Guilty to Participating in Fraud Conspiracy at New York Presbyterian Hospital 16625 2Signalife Announces Webcast 4553 1Signalife Announces Webcast 4553 2Signalife Announces Webcast 4553 3
... 2007 /Xinhua-PRNewswire-FirstCall/,-- Pharmaceuti...from its Phase II trial for Aridol in subjects wit...respiratory disease,affecting over 30 million peop...nosed COPD patients at 12,centres in Australia. Th...if subjects that were positive to an Aridol challe...
...arter BLA filing for C1-inhibitor,replacement ther...l/ -- Lev,Pharmaceuticals, Inc. (Lev) today announ...II trial of C1-esterase inhibitor (C1-INH),for the...n the,acute study, which is part of the company,s ...ma Nanofiltration Generation,evaluating Efficacy),...
Other Medicine Technology:Pharmaxis Reports Phase II Results for Aridol in COPD 2Pharmaxis Reports Phase II Results for Aridol in COPD 3Pharmaxis Reports Phase II Results for Aridol in COPD 4Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 2Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 3Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 4Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 5